Facebook Instagram Linkedin Youtube
Home Search

aptahem - search results

If you're not happy with the results, please do another search
Aptahem teams up with Hongene

Aptahem teams up with Hongene

Aptahem reports growing buzz around Apta-1

Aptahem reports growing buzz around Apta-1

Aptahem comments on the publication in Cells

Aptahem comments on the publication in Cells

Intervjubanner_BIMSeptember2023

Watch the interviews from BioStock Investor Meeting!

Companypresentations_BIM2023Sept

Watch the presentations from BioStock Investor Meeting!

Aptahem's CEO comments on Q2 and looks ahead

Aptahem’s CEO comments on Q2 and looks ahead

Aptahem comments on the paused phase I study

Aptahem comments on the paused phase I study

sepsis

Aptahem takes the next step in the treatment of sepsis

Aptahem gives update on operations and rights issue

Aptahem gives update on operations and rights issue

biostock life science summit 2023

The BioStock Life Science Spring Summit 2023 goes live today

Aptahem on the need for more effective sepsis treatments

Aptahem on the need for more effective sepsis treatments

BioStock Life Science Summit May 2023

BiBB premier

Aptahem’s CEO sees continued interest in Apta-1

BioStock Investor Meeting September 2023

Further steps in Aptahem’s phase I study

Aptahem gives update on operations and rights issue

Aptahem’s CEO on upcoming milestones

Aptahem

Aptahem’s CEO comments on the rights issue

Aptahem operational update

Aptahem provides an operational update

Aptahem

Aptahem on the application to initiate clinical studies

Aptahem on the importance of raising sepsis awareness

Aptahem on schedule for clinical studies

Aptahem increasingly close to clinical studies

Lipum has wind in its sails for phase I

Lipum has wind in its sails for phase I

Lipum

Aptahem’s new CMO on her role and vision

aptahem

Aptahem signs agreement with CRO for phase I studies

BIoStock Investor Meeting 16 mars

BioStock Investor Meeting 16 March

Aptahem

Aptahem on the latest news

Aptahem

Aptahem’s Q4 lays groundwork for clinical studies

Aptahem

Aptahem recruits to key positions before clinical studies

BioStock investor meeting March 16

BioStock Investor Meeting, March 16

Aptahem’s CEO on clinical studies in 2022

Abliva

Aptahem’s new research findings explained

BIO-Europe

Eight CEOs on their expectations at BIO-Europe

BioStock Life Science Summit 20 – 21 Oktober 2021

Join us for the BioStock Life Science Summit on October 20...

BioStock Live: World Sepsis Day Seminar with Aptahem

Aptahem’s CEO looks forward to an exciting second half of the...

Aptahem on the potential for collaboration with the US military

Sepsis – common complication in connection with Covid-19 infection

Aptahem on the company’s new research findings

Aptahem’s new CRD brings clinical experience to Phase I

Aptahem on the comparative study between Apta-1 and dexamethasone

Positive results from Aptahem’s collaboration with Örebro University

Aptahem comments on the new Covid-19 project

CombiGene’s new Chairman on visions for the future

Aptahem’s founder is back – now as Chairman of the Board

Aptahem approaching milestone via oversubscribed rights issue

Aptahem looks ahead with optimism

Aptahem’s wish list for next year’s Christmas

BioStock Studio: Aptahem´s CSO on the sepsis candidate Apta-1

Aptahem has identified a mechanism of action for Apta-1

Aptahem’s Chairman of the Board on the latest news

Aptahem’s chief operating officer on the plans for 2021

Aptahem’s Scientific Advisors on Sepsis Candidate Apta-1

Aptahem’s CEO on signing of non binding Term Sheet

Strong opening to BioStock Life Science Summit 2019 – see videos...

© BioStock 2025